3-Phenoxybenzaldehyde
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Crovalimab
Pozelimab
Pexelizumab
Gefurulimab
Gavilimomab
Olendalizumab
Avdoralimab
Vilobelimab
Tesidolumab
Vesencumab
Lampalizumab
Ravulizumab
Riliprubart
Empasiprubart
Sutimlimab
C5a Receptor agonist, W5Cha
C5a Anaphylatoxin (human)
Zilucoplan TFA